These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 12014004

  • 21. Carnitine-acylcarnitine translocase deficiency: metabolic consequences of an impaired mitochondrial carnitine cycle.
    Röschinger W, Muntau AC, Duran M, Dorland L, IJlst L, Wanders RJ, Roscher AA.
    Clin Chim Acta; 2000 Aug; 298(1-2):55-68. PubMed ID: 10876004
    [Abstract] [Full Text] [Related]

  • 22. Assays of fatty acid beta-oxidation activity.
    Bennett MJ.
    Methods Cell Biol; 2007 Aug; 80():179-97. PubMed ID: 17445695
    [No Abstract] [Full Text] [Related]

  • 23. A novel functional assay for simultaneous determination of total fatty acid beta-oxidation flux and acylcarnitine profiling in human skin fibroblasts using (2)H(31)-palmitate by isotope ratio mass spectrometry and electrospray tandem mass spectrometry.
    Law LK, Tang NL, Hui J, Ho CS, Ruiter J, Fok TF, Wanders RJ, Lam CW.
    Clin Chim Acta; 2007 Jul; 382(1-2):25-30. PubMed ID: 17442290
    [Abstract] [Full Text] [Related]

  • 24. Prospective treatment in carnitine-acylcarnitine translocase deficiency.
    Pierre G, Macdonald A, Gray G, Hendriksz C, Preece MA, Chakrapani A.
    J Inherit Metab Dis; 2007 Oct; 30(5):815. PubMed ID: 17508264
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Novel localization of OCTN1, an organic cation/carnitine transporter, to mammalian mitochondria.
    Lamhonwah AM, Tein I.
    Biochem Biophys Res Commun; 2006 Jul 14; 345(4):1315-25. PubMed ID: 16729965
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Carnitine/acylcarnitine translocase deficiency].
    Yorifuji S.
    Ryoikibetsu Shokogun Shirizu; 1998 Jul 14; (18 Pt 1):403-4. PubMed ID: 9590083
    [No Abstract] [Full Text] [Related]

  • 31. The mitochondrial carnitine/acylcarnitine carrier: function, structure and physiopathology.
    Indiveri C, Iacobazzi V, Tonazzi A, Giangregorio N, Infantino V, Convertini P, Console L, Palmieri F.
    Mol Aspects Med; 2011 Aug 14; 32(4-6):223-33. PubMed ID: 22020112
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Carnitine metabolism in livers and hearts of 48h-starved rats: the contribution of fat and carbohydrate to acylcarnitine formation.
    French TJ, Goode AW, Holness MJ, Sugden MC.
    Biochem Int; 1985 Aug 14; 11(2):265-72. PubMed ID: 4052090
    [Abstract] [Full Text] [Related]

  • 36. Enhancement of mitochondrial carnitine and carnitine acylcarnitine translocase-mediated transport of fatty acids into liver mitochondria under ketogenic conditions.
    Parvin R, Pande SV.
    J Biol Chem; 1979 Jun 25; 254(12):5423-9. PubMed ID: 447661
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Enzymes of mitochondrial beta-oxidation].
    Yamaguchi S.
    Nihon Rinsho; 2002 Apr 25; 60 Suppl 4():88-93. PubMed ID: 12014005
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.